Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2025 Earnings Call Transcript February 26, 2026 Amphastar Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.73 EPS, ...
Dalaroo Metals clinches 80% Bondoukou Gold Project in Côte d’Ivoire; mining lease secured, funded by shares/options, ...
Ariel Investments' Q4 2025 13F portfolio decreased slightly to $9.26B. Check out the significant stake increases and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results